Products Categories
CAS No.: | 5002-47-1 |
---|---|
Name: | Fluphenazine decanoate |
Molecular Structure: | |
Formula: | C32H44F3N3O2S |
Molecular Weight: | 591.781 |
Synonyms: | Decanoicacid, 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethylester (7CI,8CI);1-Piperazineethanol,4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-, decanoate (ester) (8CI);Dapotum D;Depot;Fluorophenazine decanoate;Lyogen;Modecate;Moditen depot;NSC 169510;Prolixindecanoate;QD 10733;SQ 10733; |
EINECS: | 225-672-4 |
Density: | 1.149 g/cm3 |
Melting Point: | 30-32° |
Boiling Point: | 658.1 °C at 760 mmHg |
Flash Point: | 351.8 °C |
Transport Information: | UN 3249 |
PSA: | 61.32000 |
LogP: | 7.94050 |
What can I do for you?
Get Best Price
IUPAC Name: Fluphenazine decanoate
The MF of Fluphenazine decanoate (5002-47-1) is C32H44F3N3O2S.
The MW of Fluphenazine decanoate (5002-47-1) is 591.77.
Synonyms of Fluphenazine decanoate (5002-47-1): 2-(4-{3-[2-(Trifluormethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethyldecanoat ; 2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethyl decanoate ; Decanoic acid 2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethylester
Product Categories: Organics
Index of Refraction: 1.537
EINECS: 225-672-4
Density: 1.149 g/ml
Flash Point: 351.8 °C
Boiling Point: 658.1 °C
Fluphenazine decanoate (5002-47-1) is used in organic synthesis, drug manufacturing.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intramuscular | > 1500mg/kg (1500mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 35, Pg. 799, 1993. | |
human | TDLo | intramuscular | 179ug/kg (0.179mg/kg) | BEHAVIORAL: ANTIPSYCHOTIC | American Journal of Psychiatry. Vol. 121, Pg. 784, 1965. |
man | TDLo | intramuscular | 1071ug/kg/12D (1.071mg/kg) | BEHAVIORAL: ATAXIA SKIN AND APPENDAGES (SKIN): SWEATING: OTHER LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Annals of Emergency Medicine. Vol. 16, Pg. 705, 1987. |
man | TDLo | intramuscular | 46mg/kg/5Y-I (46mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | British Journal of Psychiatry. Vol. 149, Pg. 524, 1986. |
mouse | LD50 | intramuscular | 60mg/kg (60mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 16, Pg. 87, 1990. |
rat | LD50 | intramuscular | 576mg/kg (576mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 16, Pg. 75, 1990. |
rat | LD50 | oral | 19mg/kg (19mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 16, Pg. 75, 1990. |
women | TDLo | intramuscular | 21mg/kg/6D-I (21mg/kg) | CARDIAC: PULSE RATE GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | British Medical Journal. Vol. 286, Pg. 1016, 1983. |
Safety information of Fluphenazine decanoate (5002-47-1):
RIDADR 3249
HazardClass 6.1(a)
PackingGroup II